NCT03738137

Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy

Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy Under Conscious Sedation

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Guangzhou Institute of Respiratory Disease · Academic / Other
• Sex: All
• Age: 18 Years – 69 Years
• Healthy volunteers: Accepted

Summary

This study was aimed to determine whether narcotrend monitoring was better than bispectral index monitoring during sufentanil-midazolam anesthesia for bronchoscopy under conscious sedation. Patients were randomised to receive Narcotrend, Bispectral Index(BIS) monitoring or without monitoring. Midazolam was given by non-anaesthetist physicians to achieve moderate levels of sedation as assessed by the narcotrend index (NI; B and C) or bispectral index (BIS; between 70 and 85) or according to patient's tolerance assessed by physician . The primary end-point was dosage of midazolam. Other end-points included adverse events, patient tolerance and physician satisfaction.

Conditions

• Bronchoscopy

Interventions

Type	Name	Description
DEVICE	Narotrend	Narcotrend motoring
DEVICE	BIS	Bispectral index monitoring
DRUG	Sufentanil	sufentanil is applied.
DRUG	Lidocaine	Topical Anesthesia
DRUG	Midazolam	midazolam is applied.

Timeline

• Start date: 2018-08-01
• Primary completion: 2019-01-15
• Completion: 2019-01-30
• First posted: 2018-11-13
• Last updated: 2019-04-03

Locations

1 site across 1 country: China